TITLE

FDA APPROVES TEVA'S ANDA TO MARKET GENERIC VERSION OF ZOCOR

PUB. DATE
August 2006
SOURCE
Worldwide Biotech;Aug2006, Vol. 18 Issue 8, p1
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the approval granted by the U.S. Food and Drug Administration for Teva Pharmaceutical Industries' Abbreviated New Drug Application to market its generic version of Merck's Zocor Tablets. Indication of Teva's Simvastatin Tablets; Annual brand product sales in the U.S.
ACCESSION #
21760735

 

Related Articles

  • Complex Biologies: The View from Teva. Conner, Jill B. // Pharmaceutical Executive;Sep2011, Vol. 31 Issue 9, p26 

    The article presents the author's views on work areas concerning biosimilar drugs, that need to be considered by the industry and regulators in the U.S. The author states that the approval pathway for follow-on biologies and non-biologic complex drugs (NBCDs) should be different from...

  • FDA GRANTS 'APPROVABLE' FOR TEVA'S ANDA FOR GABAPENTIN.  // Worldwide Biotech;Sep2002, Vol. 14 Issue 9, p5 

    Deals with the approval received by Teva Pharmaceutical Industries Ltd. from the U.S. Food and Drug Administration for its generic equivalent of the anticonvulsant drug of Pfizer.

  • CNS News Round-Up.  // PharmaWatch: CNS;Jul2011, Vol. 10 Issue 7, p2 

    An introduction is presented in which the editor discusses various reports within the issue on topics including the launches of the new generic version of pain and schizophrenic drugs from Mylan Pharmaceuticals Inc. and the approval issued to Teva Pharmaceutical Industries Ltd.

  • NEW GENERICS.  // Drug Topics;1/20/2003, Vol. 147 Issue 2, p69 

    Reports that tentative approval has been granted to the TEVA Pharmaceuticals to market alendronate sodium tablets, which are indicated for the treatment of osteoporosis.

  • Chain PHARMACY: REPORTERS Notebook.  // Drug Store News;5/13/2013, Vol. 35 Issue 5, p53 

    The article offers news briefs related to the generic drug industry including the launch of oxymorphone hydrochloride tablets by Teva Pharmaceutical Industries, the approval of the Daysee contraceptives from Lupin Pharmaceuticals by the U.S. Food and Drug Administration and Sandoz's launch of...

  • Pipeline.  // Medical Marketing & Media;Aug2008, Vol. 43 Issue 8, p12 

    The article offers news briefs related to the U.S. Food and Drug Administration (FDA). TEVA Pharmaceuticals secured FDA's approval for its generic versions of Risperdal tablets. The Aciphex from Esai Ltd. won FDA approval for the short-term treatment of GERD in adolescents over 12 years of age....

  • Teva Pharmaceuticals USA. Rankin, Ken // Drug Store News;8/18/97, Vol. 19 Issue 13, pCP16 

    Profiles Kulpsville, Pennsylvania-based generic drug company Teva Pharmaceutical Industries Ltd. Contact information; Financial performance; Company history; Business profile.

  • Teva markets some of top generics.  // Drug Store News;8/18/97, Vol. 19 Issue 13, pCP54 

    Reports on developments related to Teva Pharmaceutical Industries Ltd. Drugs marketed; Business operations in the United States; Company profile.

  • Focusing on new products, partnering.  // Drug Store News;2/16/98, Vol. 20 Issue 3, pCP12 

    Profiles Sellersville, Pennsylvania-based Teva Pharmaceuticals Industries Ltd. New product strategy by the company for 1998; Partnerships being planned by the company; Comment by Bill Fletcher, chief executive officer of the company.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics